Director, Clinical Value & Outcomes; CV&O

Who we are…

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Our vision is to significantly change the practice of oncology by developing medicines that provide truly meaningful improvements in quality of life and survival for people with cancer.

The Director of Clinical Value & Outcomes (CV&O) is an experienced managed care professional with expertise in clinical strategy, healthcare economic information (HCEI), and health policy. This role supports the Nuvation Bio portfolio by leading clinical value discussions for marketed and pipeline assets. The CV&O leader is a key member of the Market Access Team with strong cross-functional collaboration with Medical Affairs (including Real-World Evidence leadership).

The role represents the organization externally in credible clinical, scientific, and healthcare economic and outcomes information exchanges with payer customers, access stakeholders, and healthcare professionals.

• Lead as the external voice for clinical and health care economic information (HCEI), presenting to payers, PBMs, IDNs, health systems, and other decision-makers.
• Translate clinical data, RWE and HEOR findings into payer-relevant value narratives that inform coverage and reimbursement decisions.
• Support development and compliant dissemination of value materials including AMCP dossiers, payer slide decks, and economic framework discussions (e.g., budget impact and cost-effectiveness interpretation).
• Partner with Market Access, Medical Affairs and HEOR to align external payer insights with integrated evidence plans across pre-approval, launch, and lifecycle phases.
• Provide market feedback and insights to inform RWE prioritization, support strategy development, identify evidence gaps, and help execute RWE initiatives
• Support pathway inclusion strategies through collaboration on clinical and HEOR evidence submissions.
• Develop and maintain strong scientific and business relationships with payer and access stakeholders, while demonstrating a deep understanding of the oncology access landscape, including regional payer policies and treatment pathways.
• Capture actionable access and reimbursement insights and communicate them cross-functionally to inform strategy.
• Identify emerging access barriers, competitive dynamics, and evidence gaps based on customer dialogue.
• Ensure medical accuracy and compliance with all regulatory, legal, and company standards.

• Doctoral-level degree required (PharmD, PhD, MD/DO, or equivalent scientific/clinical degree).
• 5-10 years of relevant pharmaceutical or biotechnology industry experience in Market Access, HEOR, Medical Affairs, or outcomes-focused roles.
• A commiserate level of education and experience may be considered.
• Strong understanding of commercial and government payer dynamics, formulary decision-making, oncology pathways, and U.S. reimbursement landscapes.
• Working knowledge of HEOR methodologies including budget impact models, cost-effectiveness frameworks, PROs, and indirect treatment comparisons.
• Demonstrated expertise in communicating complex clinical and real-world evidence to payer audiences.
• Oncology experience required; NSCLC experience preferred.
• Excellent written, verbal, and executive-level communication skills.
• Team-oriented with ability to collaborate cross-functionally

• Problem-Solver - As an action-oriented self-starter, you’re eager to apply your expertise in diagnosing inefficiencies, determining root causes, and recommending solutions to complex challenges.
• Personable - You establish and nurture highly effective relationships with colleagues and key stakeholders that support and advance project goals and objectives.
• Credible - Thorough understanding of clinical methodologies and providing sound analytical support, you quickly establish credibility as a reliable resource.
• Emotional intelligence
  , curiosity, and a knack to figure out a way to build something better
• Communication - Effectively listens, conveys, and…